Processa Pharmaceuticals, Inc. - Common Stock (PCSA)

Processa Pharmaceuticals Inc. is a biopharmaceutical company focused on the development of innovative therapeutic solutions for patients with unmet medical needs

The company primarily concentrates on advancing treatments for various cancer types and gastrointestinal disorders by utilizing its proprietary drug candidates. Through rigorous research and clinical trials, Processa aims to improve patient outcomes and enhance the quality of life for those affected by serious health conditions. Its strategic approach includes leveraging repurposed existing therapies as well as developing novel compounds, highlighting its commitment to addressing significant healthcare challenges.